141 related articles for article (PubMed ID: 19932151)
1. Regulation of prostate cancer cell proliferation by somatostatin receptor activation.
Ruscica M; Arvigo M; Gatto F; Dozio E; Feltrin D; Culler MD; Minuto F; Motta M; Ferone D; Magni P
Mol Cell Endocrinol; 2010 Feb; 315(1-2):254-62. PubMed ID: 19932151
[TBL] [Abstract][Full Text] [Related]
2. Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells: effect of mono- and bi-specific somatostatin analogs on cell growth.
Ruscica M; Magni P; Steffani L; Gatto F; Albertelli M; Rametta R; Valenti L; Ameri P; Magnaghi V; Culler MD; Minuto F; Ferone D; Arvigo M
Mol Cell Endocrinol; 2014 Feb; 382(2):860-70. PubMed ID: 24211300
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin receptor-specific analogs: effects on cell proliferation and growth hormone secretion in human somatotroph tumors.
Danila DC; Haidar JN; Zhang X; Katznelson L; Culler MD; Klibanski A
J Clin Endocrinol Metab; 2001 Jul; 86(7):2976-81. PubMed ID: 11443154
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation.
Ferone D; Arvigo M; Semino C; Jaquet P; Saveanu A; Taylor JE; Moreau JP; Culler MD; Albertelli M; Minuto F; Barreca A
Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1044-50. PubMed ID: 16046458
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptors in prostate tissues and derived cell cultures, and the in vitro growth inhibitory effect of BIM-23014 analog.
Tatoud R; Degeorges A; Prévost G; Hoepffner JL; Gauvillé C; Millot G; Thomas F; Calvo F
Mol Cell Endocrinol; 1995 Sep; 113(2):195-204. PubMed ID: 8674827
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
Plonowski A; Schally AV; Letsch M; Krupa M; Hebert F; Busto R; Groot K; Varga JL
Prostate; 2002 Aug; 52(3):173-82. PubMed ID: 12111694
[TBL] [Abstract][Full Text] [Related]
7. Effects of Somatostatin Analogs and Dopamine Agonists on Insulin-Like Growth Factor 2-Induced Insulin Receptor Isoform A Activation by Gastroenteropancreatic Neuroendocrine Tumor Cells.
van Adrichem RC; de Herder WW; Kamp K; Brugts MP; de Krijger RR; Sprij-Mooij DM; Lamberts SW; van Koetsveld PM; Janssen JA; Hofland LJ
Neuroendocrinology; 2016; 103(6):815-25. PubMed ID: 26836610
[TBL] [Abstract][Full Text] [Related]
8. A functional comparison of recombinant and native somatostatin sst2 receptor variants in epithelia.
Holliday ND; Tough IR; Cox HM
Br J Pharmacol; 2007 Sep; 152(1):132-40. PubMed ID: 17603546
[TBL] [Abstract][Full Text] [Related]
9. Subtype selective interactions of somatostatin and somatostatin analogs with sst1, sst2, and sst5 in BON-1 cells.
Ludvigsen E; Stridsberg M; Taylor JE; Culler MD; Oberg K; Janson ET
Med Oncol; 2004; 21(3):285-95. PubMed ID: 15456957
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin and dopamine receptor interaction in prostate and lung cancer cell lines.
Arvigo M; Gatto F; Ruscica M; Ameri P; Dozio E; Albertelli M; Culler MD; Motta M; Minuto F; Magni P; Ferone D
J Endocrinol; 2010 Dec; 207(3):309-17. PubMed ID: 20876239
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of enhanced potency of a chimeric somatostatin-dopamine molecule, BIM-23A387, in suppressing growth hormone and prolactin secretion from human pituitary somatotroph adenoma cells.
Saveanu A; Lavaque E; Gunz G; Barlier A; Kim S; Taylor JE; Culler MD; Enjalbert A; Jaquet P
J Clin Endocrinol Metab; 2002 Dec; 87(12):5545-52. PubMed ID: 12466351
[TBL] [Abstract][Full Text] [Related]
12. Coexpression of somatostatin receptor subtype 5 affects internalization and trafficking of somatostatin receptor subtype 2.
Sharif N; Gendron L; Wowchuk J; Sarret P; Mazella J; Beaudet A; Stroh T
Endocrinology; 2007 May; 148(5):2095-105. PubMed ID: 17272399
[TBL] [Abstract][Full Text] [Related]
13. Effects of the somatostatin analog lanreotide on the circulating levels of chromogranin-A, prostate-specific antigen, and insulin-like growth factor-1 in advanced prostate cancer patients.
Berruti A; Dogliotti L; Mosca A; Tarabuzzi R; Torta M; Mari M; Gorzegno G; Fontana D; Angeli A
Prostate; 2001 May; 47(3):205-11. PubMed ID: 11351350
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin receptor subtype 1-selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line.
Zatelli MC; Tagliati F; Piccin D; Taylor JE; Culler MD; Bondanelli M; degli Uberti EC
Biochem Biophys Res Commun; 2002 Oct; 297(4):828-34. PubMed ID: 12359227
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
Arnold JT; Le H; McFann KK; Blackman MR
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
[TBL] [Abstract][Full Text] [Related]
16. In vitro antiangiogenic activity of selective somatostatin subtype-1 receptor agonists.
Bocci G; Culler MD; Fioravanti A; Orlandi P; Fasciani A; Colucci R; Taylor JE; Sadat D; Danesi R; Del Tacca M
Eur J Clin Invest; 2007 Sep; 37(9):700-8. PubMed ID: 17696959
[TBL] [Abstract][Full Text] [Related]
17. Characterization of human recombinant somatostatin sst5 receptors mediating activation of phosphoinositide metabolism.
Wilkinson GF; Feniuk W; Humphrey PP
Br J Pharmacol; 1997 May; 121(1):91-6. PubMed ID: 9146892
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterisation of native somatostatin receptors in AtT-20 mouse tumour corticotrophs.
Cervia D; Nunn C; Fehlmann D; Langenegger D; Schuepbach E; Hoyer D
Br J Pharmacol; 2003 May; 139(1):109-21. PubMed ID: 12746229
[TBL] [Abstract][Full Text] [Related]
19. Regulation of growth hormone and prolactin gene expression and secretion by chimeric somatostatin-dopamine molecules.
Gruszka A; Ren SG; Dong J; Culler MD; Melmed S
Endocrinology; 2007 Dec; 148(12):6107-14. PubMed ID: 17656461
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone affects gene expression and proliferation in human prostate cancer cells.
Bidosee M; Karry R; Weiss-Messer E; Barkey RJ
Int J Androl; 2011 Apr; 34(2):124-37. PubMed ID: 20546049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
